Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
12/2000
12/07/2000CA2374409A1 A variant of c6 .beta.-chemokine leukotactin-1(shlkn-1) with enhanced biological activity
12/07/2000CA2374310A1 Nutritional supplements
12/07/2000CA2374295A1 Il-8 receptor antagonists
12/07/2000CA2374222A1 Cytoskeleton-associated proteins
12/07/2000CA2374141A1 Osteonectin based toxic gene therapy for the treatment of calcified tumors and tissues
12/07/2000CA2374133A1 Structural models for cytoplasmic domains of transmembrane receptors
12/07/2000CA2373937A1 Alpha v integrin receptor antagonists
12/07/2000CA2373726A1 Neurotrophic factors in the treatment of peripheral nerve dysfunction of pelvic area
12/07/2000CA2373706A1 Fibrin sealants providing less inflammatory response and methods using same
12/07/2000CA2373638A1 Adam polynucleotides and polypeptides
12/07/2000CA2373547A1 Methods for induction of tolerance to adenoviral vectors and transgene products
12/07/2000CA2372249A1 Chemokine receptor ccr3 antagonists
12/07/2000CA2372242A1 Virus immunologic determinants
12/07/2000CA2372236A1 Polymorphs of crystalline (2-benzhydryl-1-azabicyclo¬2,2,2|oct-3-yl)-(5-isopropyl-2-methoxybenzyl)-amine citrate as nk-1 receptor antagonists
12/07/2000CA2372234A1 Oxazaheterocycles as protease inhibitors
12/07/2000CA2371247A1 Substantially oil-free cyclosporin compositions
12/07/2000CA2371092A1 Cell proliferation inhibitors
12/07/2000CA2370598A1 Substituted 8-phenylxanthines useful as antagonists of a2b adenosine receptors
12/07/2000CA2336262A1 Sorting nexins
12/06/2000EP1058117A1 Use of SLIM3 to bind to molecules
12/06/2000EP1057826A1 Substituted dimeric carboxamide derivatives, method for preparing them, and pharmaceutical compositions containing them
12/06/2000EP1057820A1 Arylpiperazinylalkyl-3(2H)-pyridazinones as serotonin 5HT and dopamine D2 receptor agonists
12/06/2000EP1056877A1 Self-regulated apoptosis of inflammatory cells by gene therapy
12/06/2000EP1056869A2 Cell cycle related proteins
12/06/2000EP1056856A1 Modified ciliary neurotrophic factor, method of making and methods of use thereof
12/06/2000EP1056853A2 Human channel-related molecules
12/06/2000EP1056850A2 Biotin-binding receptor molecules
12/06/2000EP1056849A1 Human smn-like protein
12/06/2000EP1056845A1 Immunological methods to modulate myostatin in vertebrate subjects
12/06/2000EP1056844A1 Human receptor gpr14, and a method of finding agonist and antagonist to human and rat gpr14
12/06/2000EP1056781A1 Treating and diagnosing macrophage-mediated diseases using fc receptor ligands
12/06/2000EP1056770A1 Novel disulfides and thiol compounds
12/06/2000EP1056768A2 Novel anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use
12/06/2000EP1056764A1 Secreted proteins and polynucleotides encoding them
12/06/2000EP1056754A1 Phosphate derivatives of diaryl 1,3,4-oxadiazolone
12/06/2000EP1056748A1 Triazolo-pyridazine derivatives as ligands for gaba receptors
12/06/2000EP1056747A1 Triazolo-pyridazine derivatives as ligands for gaba receptors
12/06/2000EP1056746A1 Triazolo-pyridazine derivatives as ligands for gaba receptors
12/06/2000EP1056744A1 6,9-disubstituted 2- trans-(4- aminocyclohexyl) amino]purines
12/06/2000EP1056743A1 Benzamine derivatives
12/06/2000EP1056733A1 Histamine h3 receptor ligands
12/06/2000EP1056732A2 4-aminothiazole derivatives, their preparation and their use as inhibitors of cyclin-dependent kinases
12/06/2000EP1056731A1 Amino acid derivatives of daryl 1,3,4-oxadiazolone
12/06/2000EP1056730A1 Benzoate derivatives of diaryl 1,3,4-oxadiazolone
12/06/2000EP1056729A1 N-[(substituted five-membered di- or triaza diunsaturated ring)carbonyl]guanidine derivatives for the treatment of ischemia
12/06/2000EP1056725A1 Inhibition of raf kinase using aryl and heteroaryl substituted heterocyclic ureas
12/06/2000EP1056724A2 Substituted cycloalkyl-4-oxonicotinic carboxamides; gaba brain receptor ligands
12/06/2000EP1056722A1 Bisulfate salt of hiv protease inhibitor
12/06/2000EP1056719A2 Inhibitors of phospholipase enzymes
12/06/2000EP1056716A1 Cyclohexanediole derivatives
12/06/2000EP1056714A1 Phenylalanine derivatives as inhibitors of alpha4 integrins
12/06/2000EP1056469A1 Novel peptide copolymer compositions
12/06/2000EP1056467A2 Method for the treatment of diseases or disorders of the inner ear
12/06/2000EP1056462A1 Use of rhamnolipids in wound healing, treating burn shock, atherosclerosis, organ transplants, depression, schizophrenia and cosmetics
12/06/2000EP1056460A1 Pharmaceutical preparations for selectively supplementing oestrogen deficiency in the central nervous system
12/06/2000EP1056452A1 Indole-3-propionic acids, salts and esters thereof used as medicaments
12/06/2000EP1056451A1 Bicyclic pyrrole derivatives as mcp-1 inhibitors
12/06/2000EP1056450A1 Farnesyl-protein transferase inhibitors
12/06/2000EP1056448A1 Pharmaceutical combinations containing tramadol
12/06/2000EP1056413A1 Injectable implants for tissue augmentation and restoration
12/06/2000EP1056358A1 Use of d-tagatose as a prebiotic food component
12/06/2000EP1024701A4 Methods and compositions for the treatment of autoimmune disease using heat shock proteins
12/06/2000EP0683670B1 Wound-healing compositions containing iodine and a sugar
12/06/2000EP0597088B1 Novel imidazole derivatives, their preparation and therapeutic applications
12/06/2000CN1275983A Nucleosides analogues, such as antivirals including inhibitors of retroviral reverse transcriptase and the DNA polymerase of hepatitis B virus (HBV)
12/06/2000CN1275979A Isoquinolines as urokinase inhibitors
12/06/2000CN1275918A Method and food product for increasing muscle protein and reducing fat in animals
12/06/2000CN1275912A Novel amide derivatives
12/06/2000CN1275911A Method of preventing or treating estrogen-dependent diseases and disorders
12/06/2000CN1275909A In-modulators
12/06/2000CN1275384A Medicine lined in health care sholes sole or insole
12/06/2000CN1275331A Higher unsaturated fatty acid composition
12/06/2000CN1059210C Process for preparation of 6-heterocyclic-4-amino-1,3,4,5-tetrahydrbenz [cd] indoles and acid additive salt used as medicine
12/06/2000CN1059126C Shuangzhuyuye liquid of health care beverage
12/06/2000CN1059114C Health care knitting yarn and preparation technique thereof
12/06/2000CN1059113C Medicinal liquor with spleen invigorating and tranquilization, intelligent promoting, and prolonging life
12/06/2000CN1059108C Health care granule medicine
12/06/2000CN1059089C Senility-proof health medicine
12/05/2000US6156894 Process for manufacturing α.sub. 1L-adrenoceptor antagonists
12/05/2000US6156881 Inhibition of cell adhesion protein-carbohydrate interactions
12/05/2000US6156799 Method of increasing bone volume using non-naturally-occurring FP selective agonists
12/05/2000US6156798 Cardiovascular disorders, nervous system disorders, antiarthritic disorders and enzyme inhibitors
12/05/2000US6156783 Spiroazabicyclic compounds, processes for their preparation, and their pharmaceutical use
12/05/2000US6156773 Pharmaceutical composition
12/05/2000US6156759 Nonnucleoside inhibitors of reverse transcriptase, composite binding pocket and method for use thereof
12/05/2000US6156756 Anticoagulants
12/05/2000US6156755 Use of pyrimidine derivatives for the prevention of cancer, on their own or in combination with other therapeutic measures
12/05/2000US6156752 Optically active 1,4-dihydropyridine compounds as bradykinin antagonists
12/05/2000US6156750 Bioactive bicyclic aromatic compounds and pharmaceutical/cosmetic compositions comprised thereof
12/05/2000US6156747 Psychological, gastrointestinal, cardiovascular disorders
12/05/2000US6156741 Nervous system disorders
12/05/2000US6156739 Quinazolinone compounds
12/05/2000US6156734 Cardiovascular disorders
12/05/2000US6156573 Hybrid Bacillus thuringiensis δ-endotoxins with novel broad-spectrum insecticidal activity
12/05/2000US6156571 Oligonucleotide of defined nucleotide sequence which hybridizes to nucleic acid encoding steroid receptor coactivator-3; diagnosis and therapy of related disorders
12/05/2000US6156535 Nucleotide sequences coding inhibitor of apoptosis protein; for diagnosing a cell proliferation defect
12/05/2000US6156523 Serine/threonine protein kinases
12/05/2000US6156518 Methods of using DNA encoding human alpha 1 adrenergic receptors
12/05/2000US6156314 Monoclonal antibodies
12/05/2000CA2188066C Thio-substituted phosphonate compounds
1 ... 1109 1110 1111 1112 1113 1114 1115 1116 1117 1118 1119 1120 1121 1122 1123 1124 1125 1126 1127 1128 1129 ... 1564